AC
VCYT icon

Allstate Corporation’s Veracyte VCYT Stock Holding History

Allstate Corporation’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,132
Closed -$335K – 762
2021
Q4 		$335K Sell
8,132
-218
-3% -$9.63K 0.01% 711
2021
Q3 		$388K Buy
8,350
+1,679
+25% +$73.3K 0.02% 563
2021
Q2 		$267K Buy
+6,671
New +$285K 0.01% 672
2021
Q1 		– Sell
-5,939
Closed -$291K – 742
2020
Q4 		$291K Sell
5,939
-998
-14% -$46.2K 0.01% 632
2020
Q3 		$225K Buy
+6,937
New +$220K 0.01% 629

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Allstate Corporation's VCYT Position: Q1 2022 in Review

Allstate Corporation sold out of Veracyte (VCYT) in Q1 2022, closing a stake of 8,132 shares — an estimated $335K sold.

Allstate Corporation first reported a position in VCYT in Q3 2020 and held it in 5 quarters. The position peaked at $388K in Q3 2021. 205 funds tracked by Wall St. Rank hold VCYT as of Q1 2022.

  • Allstate Corporation reported no remaining Veracyte position as of Q1 2022 after selling out during the quarter.
  • Allstate Corporation sold 8,132 Veracyte shares in Q1 2022, an estimated $335K.
  • Allstate Corporation first reported a position in Veracyte in Q3 2020 and held it in 5 quarters.
  • Allstate Corporation's Veracyte position peaked at $388K in Q3 2021.
  • 205 funds tracked by Wall St. Rank held Veracyte as of Q1 2022.

Based on Allstate Corporation's 13F filing for Q1 2022, filed 16 May 2022.